{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:04:11Z","timestamp":1784322251818,"version":"3.55.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.molmed.2026.06.012","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:44:49Z","timestamp":1784238289000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ubiquitin-specific peptidase 22 targeting: Tumor cell erasure, immune engine unleashed"],"prefix":"10.1016","author":[{"given":"Deyu","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2026.06.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-026-01779-6","article-title":"The landscape of the ubiquitin-proteasome system in cancer","author":"Orian","year":"2026","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2026.06.012_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188903","article-title":"USP7 \u2013 a crucial regulator of cancer hallmarks","volume":"1878","author":"Saha","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.molmed.2026.06.012_bb0015","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.celrep.2013.11.029","article-title":"USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation","volume":"5","author":"Lin","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.06.012_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molcel.2013.04.022","article-title":"USP15 negatively regulates Nr12 through deubiquitination of Keap1","volume":"51","author":"Villeneuve","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.06.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050093","article-title":"CYLD in health and disease","volume":"16","author":"Mar\u00edn-Rubio","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.molmed.2026.06.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117324","article-title":"Recent advances in small molecule inhibitors of deubiquitinating enzymes","volume":"287","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molmed.2026.06.012_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118865","article-title":"USP22 in human cancers: mechanistic insights and inhibitor development","volume":"312","author":"Zhou","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molmed.2026.06.012_bb0040","doi-asserted-by":"crossref","first-page":"44848","DOI":"10.18632\/oncotarget.8602","article-title":"Ubiquitin-specific peptidase 22 functions and its involvement in disease","volume":"7","author":"Melo-Cardenas","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.molmed.2026.06.012_bb0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","article-title":"USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development","volume":"46","author":"Lin","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.06.012_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145164","article-title":"The structural, functional, and regulatory insight of deubiquitinating enzyme - USP22","volume":"318","author":"Devi","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0055","doi-asserted-by":"crossref","DOI":"10.1242\/dev.174037","article-title":"USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta","volume":"146","author":"Koutelou","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.molmed.2026.06.012_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq2061","article-title":"Usp22 is an intracellular regulator of systemic emergency hematopoiesis","volume":"7","author":"Dietlein","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuroscience.2022.06.014","article-title":"Ubiquitin-specific protease 22 promotes neural stem cells stemness maintenance and adult hippocampal neurogenesis, contributing to cognitive recovery following traumatic brain injury","volume":"496","author":"Zhang","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmed.2026.06.012_bb0070","doi-asserted-by":"crossref","first-page":"37906","DOI":"10.18632\/oncotarget.5412","article-title":"Usp22 deficiency impairs intestinal epithelial lineage specification in vivo","volume":"6","author":"Kosinsky","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.molmed.2026.06.012_bb0075","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12012-022-09758-2","article-title":"LncRNA MALAT1 regulates USP22 expression through EZH2-mediated H3K27me3 modification to accentuate sepsis-induced myocardial dysfunction","volume":"22","author":"Xu","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0080","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41467-018-03455-x","article-title":"The H2B deubiquitinase Usp22 promotes antibody class switch recombination by facilitating non-homologous end joining","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.012_bb0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-020-2246-4","article-title":"CRISPR screen in regulatory T cells reveals modulators of Foxp3","volume":"582","author":"Cortez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.06.012_bb0090","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182218","article-title":"USP22 controls iNKT immunity through MED1 suppression of histone H2A monoubiquitination","volume":"217","author":"Zhang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2026.06.012_bb0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood-2017-10-811760","article-title":"USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism","volume":"132","author":"Melo-Cardenas","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2026.06.012_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111157","article-title":"USP22 inhibits microglial M1 polarization by regulating the PU.1\/NLRP3 inflammasome pathway","volume":"220","author":"Yu","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.molmed.2026.06.012_bb0105","article-title":"Reciprocal regulation of TNF receptor 1-mediated signaling and inflammatory damages by MARCH2 and USP22","volume":"123","author":"Li","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.06.012_bb0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.molcel.2009.06.015","article-title":"Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance","volume":"35","author":"Atanassov","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.06.012_bb0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.molcel.2007.12.011","article-title":"A TFTC\/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing","volume":"29","author":"Zhao","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.06.012_bb0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2007.12.015","article-title":"The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression","volume":"29","author":"Zhang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.06.012_bb0125","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awae160","article-title":"De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features","volume":"147","author":"Harel","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2026.06.012_bb0130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1126\/science.aac5681","article-title":"Structural basis for histone H2B deubiquitination by the SAGA DUB module","volume":"351","author":"Morgan","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.06.012_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado1533","article-title":"Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22-mediated lipolysis circuit","volume":"10","author":"Zhou","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2026.06.012_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/JCI198270","article-title":"SIRT2-mediated deacetylation activates USP22 catalytic function for PD-L1 protein stabilization and tumor immune escape","author":"Li","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.012_bb0145","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019102509","article-title":"The SAGA complex regulates early steps in transcription via its deubiquitylase module subunit USP22","volume":"40","author":"Stanek","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2026.06.012_bb0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2026.06.012_bb0155","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/onc.2016.521","article-title":"LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells","volume":"36","author":"Xiong","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2026.06.012_bb0160","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1172\/JCI97831","article-title":"Galpha12 ablation exacerbates liver steatosis and obesity by suppressing USP22\/SIRT1-regulated mitochondrial respiration","volume":"128","author":"Kim","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.012_bb0165","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1002\/jcp.25841","article-title":"Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells","volume":"232","author":"Kim","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2015.28","article-title":"Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1","volume":"1","author":"Lin","year":"2015","journal-title":"Cell Discov."},{"key":"10.1016\/j.molmed.2026.06.012_bb0175","doi-asserted-by":"crossref","first-page":"E9298","DOI":"10.1073\/pnas.1807704115","article-title":"Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells","volume":"115","author":"Gennaro","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.06.012_bb0180","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/embor.2011.140","article-title":"USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1","volume":"12","author":"Atanassov","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2026.06.012_bb0185","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2019-319616","article-title":"USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1alpha\/USP22 positive feedback loop upon TP53 inactivation","volume":"69","author":"Ling","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2026.06.012_bb0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-024-01963-5","article-title":"The p-MYH9\/USP22\/HIF-1a axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma","volume":"9","author":"Shan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.molmed.2026.06.012_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo4116","article-title":"A deubiquitination module essential for T(reg) fitness in the tumor microenvironment","volume":"8","author":"Montauti","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2026.06.012_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216872","article-title":"Tumor-associated macrophage-induced circMRCKa encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma","volume":"591","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2026.06.012_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70239","article-title":"USP22 promotes osteosarcoma progression by stabilising beta-catenin and upregulating HK2 and glycolysis","volume":"28","author":"Chen","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.molmed.2026.06.012_bb0210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s42003-025-07644-5","article-title":"Inhibition of SCF(KDM2A)\/USP22-dependent nuclear beta-catenin ubiquitylation mediates cerebral ischemic tolerance","volume":"8","author":"Zuo","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0215","article-title":"Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis","author":"Liu","year":"2024","journal-title":"Res. Sq."},{"key":"10.1016\/j.molmed.2026.06.012_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111265","article-title":"USP22 is required for human endometrial stromal cell proliferation and decidualization by deubiquitinating FoxM1","volume":"121","author":"Zhou","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.molmed.2026.06.012_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217196","article-title":"Hepatocyte growth factor promotes melanoma metastasis through ubiquitin-specific peptidase 22-mediated integrins upregulation","volume":"604","author":"Gao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2026.06.012_bb0230","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41467-022-29846-9","article-title":"USP22 regulates lipidome accumulation by stabilizing PPARgamma in hepatocellular carcinoma","volume":"13","author":"Ning","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.012_bb0235","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s42003-025-08116-6","article-title":"USP22 enhances atherosclerotic plaque stability and macrophage efferocytosis by stabilizing PPARgamma","volume":"8","author":"Tang","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0240","first-page":"773","article-title":"Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPAR-gamma","volume":"74","author":"Yang","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2026.06.012_bb0245","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ncb3396","article-title":"Nuclear GSK3beta promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22","volume":"18","author":"Zhou","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0250","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193162","article-title":"USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I","volume":"136","author":"Liu","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.012_bb0255","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/2326-6066.CIR-18-0910","article-title":"USP22 deubiquitinates CD274 to suppress anticancer immunity","volume":"7","author":"Huang","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molmed.2026.06.012_bb0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12964-020-00612-y","article-title":"The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.molmed.2026.06.012_bb0265","first-page":"5564","article-title":"The ubiquitin-specific peptidase 22 is a deubiquitinase of CD73 in breast cancer cells","volume":"12","author":"Gregory","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.012_bb0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12964-025-02642-w","article-title":"Hyperglycemia drives lmmune evasion in colorectal cancer through Vista stabilization","volume":"24","author":"Liu","year":"2026","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.molmed.2026.06.012_bb0275","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.3390\/cancers13174276","article-title":"Usp22 overexpression leads to aberrant signal transduction of cancer-related pathways but is not sufficient to drive tumor formation in mice","volume":"13","author":"Kuang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2026.06.012_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290837","article-title":"USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity","volume":"19","author":"Kuang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2026.06.012_bb0285","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-21-2106","article-title":"M6A RNA methylation regulates histone ubiquitination to support cancer growth and progression","volume":"82","author":"Yadav","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.012_bb0290","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050163","article-title":"USP22 controls necroptosis by regulating receptor-interacting protein kinase 3 ubiquitination","volume":"22","author":"Roedig","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2026.06.012_bb0295","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/0008-5472.CAN-19-1033","article-title":"USP22 functions as an oncogenic driver in prostate cancer by regulating cell proliferation and DNA repair","volume":"80","author":"McCann","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.012_bb0300","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clbc.2022.11.006","article-title":"USP22 contributes to chemoresistance, stemness, and EMT phenotype of triple-negative breast cancer cells by regulating the Warburg effect via c-Myc deubiquitination","volume":"23","author":"Li","year":"2023","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.molmed.2026.06.012_bb0305","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41388-026-03755-3","article-title":"M(6)A-dependent upregulation of ZNF460 promotes epithelial-mesenchymal transition and metastasis of gastric cancer through a histone modification-mediated positive feedback loop","volume":"45","author":"Yue","year":"2026","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2026.06.012_bb0310","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3892\/ijo.2014.2531","article-title":"USP22 promotes the G1\/S phase transition by upregulating FoxM1 expression via beta-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma","volume":"45","author":"Ning","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0315","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/1541-7786.MCR-19-0053","article-title":"USP22 interacts with PALB2 and promotes chemotherapy resistance via homologous recombination of DNA double-strand breaks","volume":"18","author":"Nardi","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.012_bb0320","article-title":"USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches","volume":"12","author":"Zhang","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.molmed.2026.06.012_bb0325","doi-asserted-by":"crossref","first-page":"24234","DOI":"10.1074\/jbc.M113.469783","article-title":"The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2)","volume":"288","author":"Sussman","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2026.06.012_bb0330","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s42003-025-07899-y","article-title":"A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogramming","volume":"8","author":"Gurhan","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0335","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2326-6066.CIR-19-0661","article-title":"Tumor cell-intrinsic USP22 suppresses antitumor immunity in pancreatic cancer","volume":"8","author":"Li","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molmed.2026.06.012_bb0340","article-title":"EZH2 inhibition enhances PD-L1 protein stability through USP22-mediated deubiquitination in colorectal cancer","volume":"11","author":"Huang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.molmed.2026.06.012_bb0345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2025.11.035","article-title":"Next steps in regulatory T cells: biology and clinical application","volume":"189","author":"Zou","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2026.06.012_bb0350","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adr7057","article-title":"Inducible protein degradation reveals inflammation-dependent function of the T(reg) cell lineage-defining transcription factor Foxp3","volume":"10","author":"J\u00e4ger","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0355","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41590-025-02295-4","article-title":"Temporal and context-dependent requirements for the transcription factor Foxp3 expression in regulatory T cells","volume":"26","author":"Hu","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0360","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-981-15-6407-9_3","article-title":"Regulation of treg functions by the ubiquitin pathway","volume":"1278","author":"Montauti","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0365","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1172\/JCI38902","article-title":"The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice","volume":"119","author":"Zhang","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.012_bb0370","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1073\/pnas.1118462109","article-title":"Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance","volume":"109","author":"Gao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.06.012_bb0375","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167728","article-title":"CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion","volume":"133","author":"Wang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.012_bb0380","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1038\/s41467-022-35469-x","article-title":"PRDM1\/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.012_bb0385","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41467-018-08123-8","article-title":"CD73 expression on effector T cells sustained by TGF-beta facilitates tumor resistance to anti-4-1BB\/CD137 therapy","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.012_bb0390","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.molmed.2026.06.012_bb0395","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41588-024-01883-8","article-title":"MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution","volume":"56","author":"Puttick","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2026.06.012_bb0400","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.semcancer.2022.11.005","article-title":"Emerging role of chemokines in small cell lung cancer: road signs for metastasis, heterogeneity, and immune response","volume":"87","author":"Khan","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0405","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2026.06.012_bb0410","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102718118","article-title":"EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner","volume":"118","author":"Bugide","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.06.012_bb0415","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.celrep.2018.03.078","article-title":"ZRANB1 is an EZH2 deubiquitinase and a potential therapeutic target in breast cancer","volume":"23","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.06.012_bb0420","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1016\/j.apsb.2025.06.027","article-title":"Deubiquitinase OTUD6A alleviates Acetaminophen-induced liver injury by targeting EZH2 to reduce cell death in hepatocytes","volume":"15","author":"Zhao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.molmed.2026.06.012_bb0425","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151666","article-title":"Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma","volume":"132","author":"Lee","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.012_bb0430","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cell.2010.04.026","article-title":"Structural basis for assembly and activation of the heterotetrameric SAGA histone H2B deubiquitinase module","volume":"141","author":"Kohler","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2026.06.012_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107509","article-title":"METTL14-mediated m6A modification enhances USP22-ERalpha axis to drive breast cancer malignancy","volume":"210","author":"Zhuang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molmed.2026.06.012_bb0440","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.chembiol.2021.12.004","article-title":"Potent macrocycle inhibitors of the human SAGA deubiquitinating module","volume":"29","author":"Morgan","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2026.06.012_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116974","article-title":"The secoiridoid glycoside Gentiopicroside is a USP22 inhibitor with potent antitumor immunotherapeutic activity","volume":"177","author":"Lu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.molmed.2026.06.012_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106842","article-title":"Discovery of selective and potent USP22 inhibitors via structure-based virtual screening and bioassays exerting anti-tumor activity","volume":"141","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.molmed.2026.06.012_bb0455","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13559","article-title":"USP21 prevents the generation of T-helper-1-like Treg cells","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.012_bb0460","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12964-023-01320-z","article-title":"Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.molmed.2026.06.012_bb0465","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191174","article-title":"USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2","volume":"217","author":"Cai","year":"2020","journal-title":"J. Exp. Med."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426001632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426001632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:21:44Z","timestamp":1784319704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491426001632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":93,"alternative-id":["S1471491426001632"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2026.06.012","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin-specific peptidase 22 targeting: Tumor cell erasure, immune engine unleashed","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2026.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}